1.Three Cases of Reconstructive Rhinoplasty Using a Local Flap or a Split Calvarial Bone Graft.
Dong Hak JUNG ; Jong Chul CHOI ; Weon Seog CHOI ; Yeong Seok YUN
Korean Journal of Otolaryngology - Head and Neck Surgery 1998;41(6):799-803
The nose is located centrally in the face and occupy an important place in the harmonic architecture of the face. Also, it plays important functions such as respiraton, olfaction and phonation. Therefore, reconstructive rhinoplasty is dealt with both cosmetic and functional aspect in mind. We have recently experienced three cases of reconstructive rhinoplasty for seborrheic keratosis of the nose, traumatic nasal defect, and basal cell carcinoma of the nose. Local flap and split calvarial bone graft were used for the reconstruction of the nose.
Carcinoma, Basal Cell
;
Keratosis, Seborrheic
;
Nose
;
Phonation
;
Rhinoplasty*
;
Smell
;
Transplants*
2.The Therapeutic Effects of the Q-Switched Nd:YAG Laser on Pigmented Lesions.
Ho JANG ; Joo Weon CHO ; Young Cheun NA ; Seog Keun YOO ; Hyeon Joon CHOI
Journal of the Korean Society of Plastic and Reconstructive Surgeons 2001;28(5):511-516
The Q-switched lasers which was introduced under the concept of selective photothermolysis. Q-switched Nd:YAG laser, which targets dark pigments in a longer wave length (1064 nm) that has less absorption by melanin, can effectively treat deep tattoos with less pigmentary alterations. We report our experience over the past 3 years in treating 565 patients with tattoos and cutaneous pigmented lesions using the Q-switched Nd:YAG laser. Patients were exposed with a pulse duration of 10 ns and fluences of 6, 7 J/cm2(1064 nm) or 12, 14 J/cm2(532 nm), in exposure spots of 2 mm or 3 mm, at intervals of 4 weeks. Q-switched Nd:YAG laser was effective in removing deep pigmented lesion with 1064 nm, and colored inks with 532 nm. Seventy-three percent of amateur black pigmented lesion were > 75% clear after four to ten treatment. Ninty-eight percent of professional black pigmented lesion were > 75% clear after two on eyebrow, six to eight on extremity and trunk. No significant side effects, including pigmentary changes or scarring, were noted.
Absorption
;
Cicatrix
;
Extremities
;
Eyebrows
;
Humans
;
Ink
;
Melanins
3.LASER Medial Arytenoidectomy in Two Patients of Bilateral Vocal Cord Palsy.
Young Mo KIM ; Jung Il CHO ; Weon Seog CHOI ; Jung Sun PARK
Korean Journal of Otolaryngology - Head and Neck Surgery 1999;42(6):791-794
Severe airway obstruction occur in bilateral vocal cord paralysis. There exists a variety of treatment methods including external and endoscopic approaches, the endoscopic LASER techniques are more desirable. However, total LASER arytenoidectomy may improve the airway but worsen the voice quality. As an alternative approach, resection medial portion of the arytenoid cartilage may improve the airway with less impairment of voice quality. Our results show that medial arytenoidectomy may be a better treatment method for bilateral vocal cord palsy than the total LASER arytenoidectomy.
Airway Obstruction
;
Arytenoid Cartilage
;
Humans
;
Vocal Cord Paralysis*
;
Vocal Cords*
;
Voice Quality
4.PLAG1, SOX10, and Myb Expression in Benign and Malignant Salivary Gland Neoplasms
Ji Hyun LEE ; Hye Ju KANG ; Chong Woo YOO ; Weon Seo PARK ; Jun Sun RYU ; Yuh Seog JUNG ; Sung Weon CHOI ; Joo Yong PARK ; Nayoung HAN
Journal of Pathology and Translational Medicine 2019;53(1):23-30
BACKGROUND: Recent findings in molecular pathology suggest that genetic translocation and/or overexpression of oncoproteins is important in salivary gland tumorigenesis and diagnosis. We investigated PLAG1, SOX10, and Myb protein expression in various salivary gland neoplasm tissues. METHODS: A total of 113 cases of surgically resected salivary gland neoplasms at the National Cancer Center from January 2007 to March 2017 were identified. Immunohistochemical staining of PLAG1, SOX10, and Myb in tissue samples was performed using tissue microarrays. RESULTS: Among the 113 cases, 82 (72.6%) were benign and 31 (27.4%) were malignant. PLAG1 showed nuclear staining and normal parotid gland was not stained. Among 48 cases of pleomorphic adenoma, 29 (60.4%) were positive for PLAG1. All other benign and malignant salivary gland neoplasms were PLAG1-negative. SOX10 showed nuclear staining. In normal salivary gland tissues SOX10 was expressed in cells of acinus and intercalated ducts. In benign tumors, SOX10 expression was observed in all pleomorphic adenoma (48/48), and basal cell adenoma (3/3), but not in other benign tumors. SOX10 positivity was observed in nine of 31 (29.0%) malignant tumors. Myb showed nuclear staining but was not detected in normal parotid glands. Four of 31 (12.9%) malignant tumors showed Myb positivity: three adenoid cystic carcinomas (AdCC) and one myoepithelial carcinoma with focal AdCC-like histology. CONCLUSIONS: PLAG1 expression is specific to pleomorphic adenoma. SOX10 expression is helpful to rule out excretory duct origin tumor, but its diagnostic value is relatively low. Myb is useful for diagnosing AdCC when histology is unclear in the surgical specimen.
Adenoma
;
Adenoma, Pleomorphic
;
Antibody-Dependent Cell Cytotoxicity
;
Carcinogenesis
;
Carcinoma, Adenoid Cystic
;
Diagnosis
;
Immunohistochemistry
;
Oncogene Proteins
;
Oncogene Proteins v-myb
;
Parotid Gland
;
Pathology, Molecular
;
Salivary Gland Neoplasms
;
Salivary Glands
;
SOX Transcription Factors
;
Translocation, Genetic
5.Soluble factor from tumor cells induces heme oxygenase-1 by a nitric oxide-independent mechanism in murine peritoneal macrophages.
Sang Wook KIM ; Hyun Mee OH ; Beom Su KIM ; Hun Taeg CHUNG ; Weon Cheol HAN ; Eun Cheol KIM ; Tae Hyeon KIM ; Geom Seog SEO ; June Hyung LYOU ; Yong Ho NAH ; Jae Chang JUNG ; Suck Chei CHOI ; Chang Duk JUN
Experimental & Molecular Medicine 2003;35(1):53-59
Tumor target-derived soluble secretary factor has been known to influence macrophage activation to induce nitric oxide (NO) production. Since heme oxigenase-1 (HO-1) is induced by a variety of conditions associated with oxidative stress, we questioned whether soluble factor from tumor cells induces HO-1 through NO-dependent mechanism in macrophages. We designated this factor as a tumor-derived macrophage-activating factor (TMAF), because of its ability to activate macrophages to induce iNOS. Although TMAF alone showed modest activity, TMAF in combination with IFN-gamma significantly induced iNOS expression and NO synthesis. Simultaneously, TMAF induced HO-1 and this induction was slightly augmented by IFN-gamma. Surprisingly, however, induction of HO-1 by TMAF was not inhibited by the treatment with the highly selective iNOS inhibitor, 1400 W, indicating that TMAF induces the HO-1 enzyme by a NO-independent mechanism. While rIFN-gamma alone induced iNOS, it had no effect on HO-1 induction by itself. Collectively, the current study reveals that soluble factor from tumor target cells induces HO-1 enzyme in macrophages. However, overall biological significance of this phenomenon remains to be determined.
Animals
;
Antineoplastic Agents/pharmacology
;
Bladder Neoplasms/metabolism/pathology
;
Cell Line
;
Drug Interactions
;
Gene Expression Regulation, Enzymologic/drug effects
;
Heme Oxygenase (Decyclizing)/analysis/*genetics
;
Human
;
Interferon Type II/pharmacology
;
Macrophage Activation/drug effects
;
Macrophages, Peritoneal/*metabolism
;
Mice
;
Mice, Inbred C57BL
;
Nitric Oxide/biosynthesis/*metabolism
;
Nitric-Oxide Synthase/genetics/metabolism
;
Nitrites/analysis
;
Tumor Cells, Cultured